Johnson & Johnson
Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About JNJ
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments.
JNJ Key Statistics
Stock Snapshot
With a market cap of 472.14B, Johnson & Johnson(JNJ) trades at $196.71. The stock has a price-to-earnings ratio of 18.91 and currently yields dividends of 2.6%.
On 2025-11-15, Johnson & Johnson(JNJ) stock traded between a low of $193.55 and a high of $197.34. Shares are currently priced at $196.71, which is +1.6% above the low and -0.3% below the high.
Johnson & Johnson(JNJ) shares are trading with a volume of 8.82M, against a daily average of 7.26M.
In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $197.34 and a 52-week low of $140.68.
In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $197.34 and a 52-week low of $140.68.
JNJ News
New insider activity at CVRx ( (CVRX) ) has taken place on November 14, 2025. Meet Your ETF AI Analyst Discover how TipRanks' ETF AI Analyst can help you make s...
Below is Validea's guru fundamental report for JOHNSON & JOHNSON (JNJ). Of the 22 guru strategies we follow, JNJ rates highest using our P/B Growth Investor mod...
Bristol Myers Squibb (BMY) in collaboration with Johnson & Johnson (JNJ) announced the decision to stop the Phase 3 Librexia ACS trial evaluating the efficacy a...
Analyst ratings
57%
of 28 ratingsMore JNJ News
Wondering if Johnson & Johnson’s stock is worth your investment dollars? Let’s break down the numbers and see if the price matches the company’s potential. Aft...
Below is Validea's guru fundamental report for JOHNSON & JOHNSON (JNJ). Of the 22 guru strategies we follow, JNJ rates highest using our Shareholder Yield Inves...
These companies are demonstrating their ability to deal with significant business risks. Dividend investing has proven to be an effective strategy for long-ter...
The latest tally of analyst opinions from the major brokerage houses shows that among the 30 stocks making up the Dow Jones Industrial Average, Johnson & Johnso...